UGCG and Gaucher disease: Adamantan-1-yl-methoxy-functionalized 1-DNJ derivatives are more potent inhibitors of glucosylceramide synthase than the therapeutic agent Zavesca that is indicated for the treatment of Gaucher disease [13].